0001628280-23-002987.txt : 20230209
0001628280-23-002987.hdr.sgml : 20230209
20230209165059
ACCESSION NUMBER: 0001628280-23-002987
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230130
FILED AS OF DATE: 20230209
DATE AS OF CHANGE: 20230209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kabbinavar Fairooz
CENTRAL INDEX KEY: 0001774182
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35558
FILM NUMBER: 23607022
MAIL ADDRESS:
STREET 1: C/O TOCAGEN INC.
STREET 2: 4242 CAMPUS POINT COURT, STE. 500
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cardiff Oncology, Inc.
CENTRAL INDEX KEY: 0001213037
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 272004382
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-952-7570
MAIL ADDRESS:
STREET 1: 11055 FLINTKOTE AVENUE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Trovagene, Inc.
DATE OF NAME CHANGE: 20130304
FORMER COMPANY:
FORMER CONFORMED NAME: TrovaGene Inc.
DATE OF NAME CHANGE: 20110830
FORMER COMPANY:
FORMER CONFORMED NAME: XENOMICS INC
DATE OF NAME CHANGE: 20040719
3
1
wf-form3_167597942775635.xml
FORM 3
X0206
3
2023-01-30
0
0001213037
Cardiff Oncology, Inc.
CRDF
0001774182
Kabbinavar Fairooz
C/O CARDIFF ONCOLOGY, INC.
11055 FLINTKOTE AVE
SAN DIEGO
CA
92121
0
1
0
0
Chief Medical Officer
Stock Options
1.75
2033-01-30
Common Stock
425000.0
D
25% of the shares subject to the option will vest on January 30, 2024 and the remaining shares vest in 36 equal monthly installments thereafter, subject to Dr. Kabbinavar's continued service.
/s/ Fairooz Kabbinavar
2023-02-09